The pathogenesis of MPSPS shall be established by aberrant membrane trafficking through the reduced abundance of VPS33A and/or by a specific function yet to be known of the VPS33A p.R498W variant on GAG metabolism. The gene discussed is VPS33A; the disease is mucopolysaccharidosis-plus syndrome.